6MO7
N-terminal bromodomain of human BRD2 with N-((4-(3-(N-cyclopentylsulfamoyl)-4-methylphenyl)-3-methylisoxazol-5-yl)methyl)acetamide inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 |
Temperature [K] | 100 |
Detector technology | IMAGE PLATE |
Collection date | 2012-08-14 |
Detector | RIGAKU RAXIS IV |
Wavelength(s) | 1.54 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 116.058, 55.833, 68.467 |
Unit cell angles | 90.00, 95.24, 90.00 |
Refinement procedure
Resolution | 30.612 - 1.850 |
R-factor | 0.1915 |
Rwork | 0.189 |
R-free | 0.22990 |
RMSD bond length | 0.007 |
RMSD bond angle | 0.901 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHENIX |
Refinement software | PHENIX (1.7_650) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 1.920 |
High resolution limit [Å] | 1.845 | 1.850 |
Rmerge | 0.048 | 0.470 |
Number of reflections | 37482 | 3699 |
<I/σ(I)> | 17.4 | 2.5 |
Completeness [%] | 99.7 | 100 |
Redundancy | 3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 33% PEG 3350 150mM ammonium sulfate 100mM HEPES pH 7.5 |